Feasibility Study of Novice-Performed Lung Ultrasound for Pneumothorax Detection After Cardiac Surgery

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorJacobo Moreno Garijo

About this trial

What is the purpose of this study? This study is being done to find out if medical trainees (such as residents and fellows) can learn to use lung ultrasound to detect a collapsed lung (pneumothorax) after heart surgery.

Who is participating in the study? Adults who have recently had heart surgery and are having their chest tubes removed in the intensive care unit may be able to join.

What will happen during the study? After chest tubes are removed, a trained medical trainee will use a small ultrasound device to check the lungs at the bedside. The patient will also have a chest X-ray, which is the usual test. The results from the ultrasound will be compared to the chest X-ray and reviewed by expert doctors.

What is the goal of the study? The goal is to see if it is possible to train medical trainees to use lung ultrasound safely and accurately in real hospital settings. The results will help plan a larger study in the future.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Age 18 years or older

Undergoing cardiac surgery

Scheduled for chest and/or mediastinal chest tube removal in the cardiovascular intensive care unit (CVICU)

Disqualifiers

Subcutaneous emphysema

COPD or emphysema with FEV₁ < 50% predicted

Interstitial lung disease with FEV₁ < 75% predicted

Documented history of pneumothorax prior to chest tube removal requiring intervention

Trial population

This study will enroll adult patients (18 years or older) who have undergone cardiac surgery and are scheduled for chest and/or mediastinal chest tube removal in the cardiovascular intensive care unit (CVICU). Participants will be recruited from three high-volume cardiac centers in Ontario, Canada: Sunnybrook Health Sciences Centre, Toronto General Hospital, and London Health Sciences Centre. Patients must be able to safely undergo both lung ultrasound and chest X-ray after chest tube removal. Individuals with severe lung disease or who are mechanically ventilated at the time of eligibility screening will be excluded.

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

Not listed

Trial groups

120 Participants
are grouped into 1 trial group
Group A: Post-Cardiac Surgery Patients Undergoing Chest Tube Removal

Trial outcomes

Primary outcomes

1

Recruitment Rate Across Sites

Recruitment feasibility will be measured by the number of participants enrolled per site per month. The target is at least 2 patients per site per month across three participating centers. Unit of Measure: Participants per site per month

Time frame
Up to 12 months after study start
2

Protocol Adherence to Lung Ultrasound Procedures

Percentage of enrolled participants with complete protocol adherence, defined as having both lung ultrasound and chest X-ray performed and documented as per protocol, including all required images and forms. Unit of Measure: Percentage.

Time frame
Up to 12 months after study start
3

Participant Attrition Rate

Percentage of enrolled participants who withdraw or are lost to follow-up before completion of study procedures. The study aims to maintain an attrition rate below 10%. Unit of Measure: Percentage.

Time frame
Up to 12 months after study start
4

Inter-Rater Agreement Between Novice and Expert Ultrasound Reviewers

Inter-rater reliability for lung ultrasound interpretation between novice trainees and expert reviewers, measured using kappa statistics. The target agreement is a kappa ≥ 0.8. Unit of Measure: Kappa statistic.

Time frame
Up to 12 months after study start

Secondary outcomes

1

Diagnostic Agreement Between Novice-Performed Lung Ultrasound and Chest X-Ray for Pneumothorax Detection

This outcome compares the diagnostic accuracy of lung ultrasound performed by trained medical trainees to standard chest X-ray for pneumothorax detection following chest tube removal. Agreement will be assessed using kappa statistics. Expert reviewers will independently evaluate LUS images while radiologists will interpret CXR images, both blinded to each other's findings.

Time frame
Up to 2 hours after chest tube removal on Day 0
2

Time to Diagnosis: Lung Ultrasound vs. Chest X-Ray

Compare the time from chest tube removal to pneumothorax diagnosis using lung ultrasound versus chest X-ray. Time will be measured in minutes from tube removal to the documented result of each imaging modality.

Time frame
Up to 2 hours after chest tube removal on Day 0
3

Patient-Reported Experience With Lung Ultrasound

Assess patient-reported comfort, acceptability, and imaging preference using a short questionnaire with Likert-scale responses following lung ultrasound.

Time frame
Immediately after lung ultrasound on Day 0
4

Adverse Events Related to Missed Pneumothorax

Monitor for complications associated with missed or delayed pneumothorax diagnosis, including respiratory failure, chest tube reinsertion, ICU readmission, or in-hospital mortality.

Time frame
From chest tube removal through hospital discharge (up to 14 days, based on the expected max stay)

Other outcomes

1

Diagnostic Sensitivity and Specificity of Lung Ultrasound vs. Chest X-Ray

Sensitivity and specificity of novice-performed lung ultrasound will be calculated for pneumothorax detection, using expert-reviewed chest X-ray as the clinical standard.

Time frame
Within 2 hours of chest tube removal
2

Image Quality Scores of Trainee-Performed Lung Ultrasound

Expert reviewers will assess image quality using a 3-point scale (inadequate, adequate, optimal) for each LUS exam performed by trainees. The proportion of adequate or better images will be reported.

Time frame
Immediately following each lung ultrasound (same day as chest tube removal)

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Jacobo Moreno Garijo

Lead sponsor

Sunnybrook Health Sciences Centre

Sponsor institution

Sunnybrook Health Sciences Centre

Collaborator

Toronto General Hospital

Collaborator

London Health Sciences Centre

Collaborator